Eve Holding, Inc. remains a Buy with price targets of $4.17-$5.10, representing 15%-40% upside potential. Learn more about ...

Here’s a bit of good news for air travelers who’ve had to endure weeks of headaches. Frontier Airlines has cut the price of ...

At 2,010 meters, with the scent of burned powder hanging over the lane and the wind shifting like a living thing in the ...

Eyal Cohen reported, "the US dollar devalued against the Israeli shekel by about 11% in the six months ended September 30," ...

After the first month of the 2025-26 NBA season, the OKC Thunder and Detroit Pistons are tops in the class. But there are ...

Terrorist organizations are rarely random or senseless in their acts of violence. Rather, their attacks are ...

Although UOB’s decision to accelerate the build-up of its performing loan coverage dampened overall sector earnings, ...

If you’ve chosen a target asset allocation—the mix of stocks, bonds, and cash in your portfolio— you’re probably ahead of many investors. But unless you’re ...

Jujutsu Kaisen has several powerful characters, but which ten of them stand on top even after the ending? Read on to find out ...

Blue Owl Capital terminated its merger with Blue Owl Capital Corporation II, leading to a 20% discount to net asset value.

Researchers are expanding the scope of cell and gene therapies to target chronic diseases that are difficult to treat.

Earlier this week, Brokerage firm Rothschild is turning more cautious on the hyperscalers, downgrading Microsoft and Amazon ...